Synopsis
Motivation:
Goals:
Approach:
Results:
669-02-004
ISMRM Abstract
Quantitative oxygen extraction fraction (OEF) mapping in Huntington’s disease
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993; 72: 971–983. 1993/03/26. DOI: 10.1016/0092-8674(93)90585-e. [doi]
2. Roussakis AA and Piccini P. PET Imaging in Huntington's Disease. J Huntingtons Dis 2015; 4: 287–296. 2015/12/20. DOI: 10.3233/jhd-150171. [doi]
3. Jiang D and Lu H. Cerebral oxygen extraction fraction MRI: Techniques and applications. Magnetic Resonance in Medicine 2022; 88: 575–600. DOI: https://doi.org/10.1002/mrm.29272. [doi]
4. Kudo K, Liu T, Murakami T, et al. Oxygen extraction fraction measurement using quantitative susceptibility mapping: Comparison with positron emission tomography. Journal of Cerebral Blood Flow & Metabolism 2015; 36: 1424–1433. DOI: 10.1177/0271678X15606713. [doi]
5. Biondetti E, Cho J and Lee H. Cerebral oxygen metabolism from MRI susceptibility. NeuroImage 2023; 276: 120189. DOI: https://doi.org/10.1016/j.neuroimage.2023.120189. [doi]
6. Klinkmueller P, Kronenbuerger M, Miao X, et al. Impaired response of cerebral oxygen metabolism to visual stimulation in Huntington's disease. J Cereb Blood Flow Metab 2021; 41: 1119–1130. 20200817. DOI: 10.1177/0271678x20949286. [doi]
7. Cho J, Kee Y, Spincemaille P, et al. Cerebral metabolic rate of oxygen (CMRO(2) ) mapping by combining quantitative susceptibility mapping (QSM) and quantitative blood oxygenation level-dependent imaging (qBOLD). Magn Reson Med 2018; 80: 1595–1604. 20180307. DOI: 10.1002/mrm.27135. [doi]
8. Misra A and Cho J. An Optimal, Routinely Applicable Multi-Echo Gradient Echo (mGRE) Data Acquisition Scheme for QQ-based Oxygen Extraction Fraction (OEF) Mapping.
9. Cho J, Zhang S, Kee Y, et al. Cluster analysis of time evolution (CAT) for quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent magnitude (qBOLD)-based oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO(2) ) mapping. Magn Reson Med 2020; 83: 844–857. 20190910. DOI: 10.1002/mrm.27967. [doi]
10. Cho J, Spincemaille P, Nguyen TD, et al. Temporal clustering, tissue composition, and total variation for mapping oxygen extraction fraction using QSM and quantitative BOLD. Magn Reson Med 2021; 86: 2635–2646. 20210610. DOI: 10.1002/mrm.28875. [doi]
11. Cho J, Zhang J, Spincemaille P, et al. QQ-NET - using deep learning to solve quantitative susceptibility mapping and quantitative blood oxygen level dependent magnitude (QSM+qBOLD or QQ) based oxygen extraction fraction (OEF) mapping. Magn Reson Med 2022; 87: 1583–1594. 20211031. DOI: 10.1002/mrm.29057. [doi]
12. Hubertus S, Thomas S, Cho J, et al. Using an artificial neural network for fast mapping of the oxygen extraction fraction with combined QSM and quantitative BOLD. Magn Reson Med 2019; 82: 2199–2211. 20190704. DOI: 10.1002/mrm.27882. [doi]
13. Cho J, Zhang J, Spincemaille P, et al. Multi-Echo Complex Quantitative Susceptibility Mapping and Quantitative Blood Oxygen Level-Dependent Magnitude (mcQSM + qBOLD or mcQQ) for Oxygen Extraction Fraction (OEF) Mapping. Bioengineering 2024; 11: 131.
14. Cho J, Lee J, An H, et al. Cerebral oxygen extraction fraction (OEF): Comparison of challenge-free gradient echo QSM+qBOLD (QQ) with (15)O PET in healthy adults. J Cereb Blood Flow Metab 2021; 41: 1658–1668. 20201127. DOI: 10.1177/0271678x20973951. [doi]
15. Cho J, Ma Y, Spincemaille P, et al. Cerebral oxygen extraction fraction: Comparison of dual-gas challenge calibrated BOLD with CBF and challenge-free gradient echo QSM+qBOLD. Magn Reson Med 2021; 85: 953–961. 20200811. DOI: 10.1002/mrm.28447. [doi]
16. Elanghovan P, Nguyen T, Spincemaille P, et al. Sensitivity assessment of QSM+qBOLD (or QQ) in detecting elevated oxygen extraction fraction (OEF) in physiological change. J Cereb Blood Flow Metab 2024: 271678x241298584. 20241105. DOI: 10.1177/0271678x241298584. [doi]
17. Zhang S, Cho J, Nguyen TD, et al. Initial Experience of Challenge-Free MRI-Based Oxygen Extraction Fraction Mapping of Ischemic Stroke at Various Stages: Comparison With Perfusion and Diffusion Mapping. Frontiers in Neuroscience 2020; 14. Original Research. DOI: 10.3389/fnins.2020.535441. [doi]
18. Wu D, Zhou Y, Cho J, et al. The Spatiotemporal Evolution of MRI-Derived Oxygen Extraction Fraction and Perfusion in Ischemic Stroke. Frontiers in Neuroscience 2021; 15. Original Research. DOI: 10.3389/fnins.2021.716031. [doi]
19. Zhang S, Cho J, Nguyen TD, et al. Initial experience using combined quantitative susceptibility mapping and quantitative bold oxygen level dependent imaging (QSM+ qBOLD) oxygen extraction fraction for evaluation of acute ischemic stroke.
20. Cho J, Zhang S, Kee Y, et al. Data-driven regularized inversion (DRI) for improved QSM+ qBOLD based CMRO2 Mapping: a feasibility study in healthy subjects and ischemic stroke patients.
21. Yang L, Cho J, Chen T, et al. Oxygen extraction fraction (OEF) assesses cerebral oxygen metabolism of deep gray matter in patients with pre-eclampsia. European Radiology 2022; 32: 6058–6069. DOI: 10.1007/s00330-022-08713-7. [doi]
22. Zhang Q, Sui C, Cho J, et al. Assessing Cerebral Oxygen Metabolism Changes in Patients With Preeclampsia Using Voxel-Based Morphometry of Oxygen Extraction Fraction Maps in Magnetic Resonance Imaging. Korean J Radiol 2023; 24: 324–337. 20230307. DOI: 10.3348/kjr.2022.0652. [doi]
23. Zhuang H, Cho J, Chiang GC-Y, et al. Cerebral oxygen extraction fraction declines with ventricular enlargement in patients with normal pressure hydrocephalus. Clinical Imaging 2023; 97: 22–27. DOI: https://doi.org/10.1016/j.clinimag.2023.02.001. [doi]
24. Cho J, Nguyen TD, Huang W, et al. Brain oxygen extraction fraction mapping in patients with multiple sclerosis. Journal of Cerebral Blood Flow & Metabolism 2021; 42: 338–348. DOI: 10.1177/0271678X211048031. [doi]
25. Xie Y, Zhang S, Wu D, et al. The changes of oxygen extraction fraction in different types of lesions in relapsing–remitting multiple sclerosis: A cross-sectional and longitudinal study. Neurological Sciences 2024; 45: 3939–3949. DOI: 10.1007/s10072-024-07463-2. [doi]
26. Cho J, Nguyen TD, Huang W, et al. Regional oxygen extract fraction mapping (rOEF) of multiple sclerosis brains.
27. Yan S, Lu J, Li Y, et al. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson’s disease. European Radiology 2024; 34: 3074–3083. DOI: 10.1007/s00330-023-10283-1. [doi]
28. Shen N, Zhang S, Cho J, et al. Application of Cluster Analysis of Time Evolution for Magnetic Resonance Imaging -Derived Oxygen Extraction Fraction Mapping: A Promising Strategy for the Genetic Profile Prediction and Grading of Glioma. Frontiers in Neuroscience 2021; 15. Original Research. DOI: 10.3389/fnins.2021.736891. [doi]
29. Hubertus S, Thomas S, Cho J, et al. In MRI-based oxygen extraction fraction and cerebral metabolic rate of oxygen mapping in high-grade glioma using a combined quantitative susceptibility mapping and quantitative blood oxygenation level-dependent approach. Proceedings of the International Society for Magnetic Resonance in Medicine, Montréal, QC, Canada 2019: 11–16.
30. van Grinsven EE, de Leeuw J, Siero JCW, et al. Evaluating Physiological MRI Parameters in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery—A Preliminary Analysis and Case Report. Cancers 15. DOI: 10.3390/cancers15174298. [doi]
31. Wang J, Cho J, Zhang C, et al. Assessment of age-related changes of oxygen extraction fraction in of normal adults using QSM and quantitative BOLD.
32. Wu D, Li Y, Zhang S, et al. Trajectories and sex differences of brain structure, oxygenation and perfusion functions in normal aging. Neuroimage 2024; 302: 120903. 20241024. DOI: 10.1016/j.neuroimage.2024.120903. [doi]
33. Chiang GC, Cho J, Dyke J, et al. Brain oxygen extraction and neural tissue susceptibility are associated with cognitive impairment in older individuals. Journal of Neuroimaging 2022; 32: 697–709. DOI: https://doi.org/10.1111/jon.12990. [doi]
34. Zhang S, Ma J, Wu S, et al. Evaluation of MRI-based brain oxygen extraction fraction mapping in patients with systemic lupus erythematosus. Lupus Science & Medicine 2025; 12: e001522. DOI: 10.1136/lupus-2025-001522. [doi]
35. Misra A, Wang Y, Chiang GC, et al. Oxygen extraction fraction is differently associated with pathological biomarkers in Alzheimer’s Disease and non-Alzheimer’s dementias.
36. Misra A, Oros-Peusquens A-M, Reetz K, et al. Assessing Abnormal Oxygen Extraction Fraction and Neural Tissue Susceptibility in Parkinson's Disease. Available at SSRN 5184105.
37. Zhang R, Lin M, Cho J, et al. Oxygen extraction fraction in small vessel disease: relationship to disease burden and progression. Brain 2025; 148: 1950–1962. DOI: 10.1093/brain/awae383. [doi]
38. Yan S, Lu J, Duan B, et al. Potential separation of multiple system atrophy and Parkinson’s disease by susceptibility-derived components. NeuroImage 2025; 318: 121241. DOI: https://doi.org/10.1016/j.neuroimage.2025.121241. [doi]
39. Vallejos G, Khalil MH, Keyes S, et al. Utilizing Oxygen Extraction Fraction to differentiate Multiple Sclerosis from Non-Multiple Sclerosis Fluid-Attenuated Inversion Recovery White Matter Lesions. In: MULTIPLE SCLEROSIS JOURNAL 2024, pp.933–934. SAGE PUBLICATIONS LTD 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND.
40. Hosseini SA, Servaes S, Therriault J, et al. Quantitative evaluation of oxygen extraction fraction (OEF) in Alzheimer's disease: A correlation with tau and amyloid pathology and cognitive status. Journal of the Neurological Sciences 2023; 455. DOI: 10.1016/j.jns.2023.121101. [doi]
41. Cho J, Lv H, Guo L, et al. Neuroimaging of Brain Structure-Function Coupling Mechanism in Neuropsychiatric Disorders. Frontiers Media SA, 2023.
42. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 1996; 11: 136–142. DOI: 10.1002/mds.870110204. [doi]
43. Mestre TA, van Duijn E, Davis AM, et al. Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations. Movement Disorders 2016; 31: 1466–1478. DOI: https://doi.org/10.1002/mds.26675. [doi]
44. Cho J, Kee Y, Spincemaille P, et al. Cerebral metabolic rate of oxygen (CMRO2 ) mapping by combining quantitative susceptibility mapping (QSM) and quantitative blood oxygenation level-dependent imaging (qBOLD). Magn Reson Med 2018; 80: 1595–1604. 2018/03/09. DOI: 10.1002/mrm.27135. [doi]
45. Cho J, Zhang S, Kee Y, et al. Cluster analysis of time evolution (CAT) for quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent magnitude (qBOLD)-based oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO2 ) mapping. Magn Reson Med 2020; 83: 844–857. 2019/09/11. DOI: 10.1002/mrm.27967. [doi]
46. Hubertus S, Thomas S, Cho J, et al. Comparison of gradient echo and gradient echo sampling of spin echo sequence for the quantification of the oxygen extraction fraction from a combined quantitative susceptibility mapping and quantitative BOLD (QSM+ qBOLD) approach. Magnetic resonance in medicine 2019; 82: 1491–1503.
47. Liu Z, Spincemaille P, Yao Y, et al. MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping. Magn Reson Med 2018; 79: 2795–2803. 2017/10/13. DOI: 10.1002/mrm.26946. [doi]
48. Wen Y, Spincemaille P, Nguyen T, et al. Multiecho complex total field inversion method (mcTFI) for improved signal modeling in quantitative susceptibility mapping. Magnetic Resonance in Medicine 2021; 86: 2165–2178. DOI: https://doi.org/10.1002/mrm.28814. [doi]
49. Ma Y, Mazerolle EL, Cho J, et al. Quantification of brain oxygen extraction fraction using QSM and a hyperoxic challenge. Magn Reson Med 2020; 84: 3271–3285. 20200630. DOI: 10.1002/mrm.28390. [doi]
50. Zhang J, Cho J, Zhou D, et al. Quantitative susceptibility mapping-based cerebral metabolic rate of oxygen mapping with minimum local variance. Magn Reson Med 2018; 79: 172–179. 20170310. DOI: 10.1002/mrm.26657. [doi]
51. Zhang J, Zhou D, Nguyen TD, et al. Cerebral metabolic rate of oxygen (CMRO2 ) mapping with hyperventilation challenge using quantitative susceptibility mapping (QSM). Magn Reson Med 2017; 77: 1762–1773. 2016/04/28. DOI: 10.1002/mrm.26253. [doi]
52. Zhang J, Liu T, Gupta A, et al. Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2 ) using quantitative susceptibility mapping (QSM). Magn Reson Med 2015; 74: 945–952. 20140926. DOI: 10.1002/mrm.25463. [doi]
53. Ulrich X and Yablonskiy DA. Separation of cellular and BOLD contributions to T2* signal relaxation. Magn Reson Med 2016; 75: 606–615. 2015/03/11. DOI: 10.1002/mrm.25610. [doi]
54. He X, Zhu M and Yablonskiy DA. Validation of oxygen extraction fraction measurement by qBOLD technique. Magn Reson Med 2008; 60: 882–888. DOI: 10.1002/mrm.21719. [doi]
55. Yablonskiy DA, Sukstanskii AL and He X. Blood oxygenation level-dependent (BOLD)-based techniques for the quantification of brain hemodynamic and metabolic properties - theoretical models and experimental approaches. NMR Biomed 2013; 26: 963–986. 20120828. DOI: 10.1002/nbm.2839. [doi]
56. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341–355. 2002/02/08. DOI: 10.1016/s0896-6273(02)00569-x. [doi]
57. Faria AV, Ratnanather JT, Tward DJ, et al. Linking white matter and deep gray matter alterations in premanifest Huntington disease. Neuroimage Clin 2016; 11: 450–460. 20160226. DOI: 10.1016/j.nicl.2016.02.014. [doi]
58. Nopoulos P, Paulsen J, Beglinger L, et al. Abnormal Structure of Cerebral White and Cortical Gray Matter in Preclinical Huntington’s Disease. Neurotherapeutic 2008; 5: 369–370. DOI: 10.1016/j.nurt.2007.10.021. [doi]
59. Hu B, Younes L, Bu X, et al. Mixed longitudinal and cross-sectional analyses of deep gray matter and white matter using diffusion weighted images in premanifest and manifest Huntington's disease. Neuroimage Clin 2023; 39: 103493. 20230809. DOI: 10.1016/j.nicl.2023.103493. [doi]
60. Sweidan W, Bao F, Bozorgzad NS, et al. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis. J Neuroimaging 2020; 30: 351–358. 20200303. DOI: 10.1111/jon.12699. [doi]
61. Agus F, Crespo D, Myers RH, et al. The caudate nucleus undergoes dramatic and unique transcriptional changes in human prodromal Huntington's disease brain. BMC Med Genomics 2019; 12: 137. 20191016. DOI: 10.1186/s12920-019-0581-9. [doi]
62. Aylward EH, Rosenblatt A, Field K, et al. Caudate volume as an outcome measure in clinical trials for Huntington’s disease: a pilot study. Brain Research Bulletin 2003; 62: 137–141. DOI: https://doi.org/10.1016/j.brainresbull.2003.09.005. [doi]
63. Kasper J, Eickhoff SB, Caspers S, et al. Local synchronicity in dopamine-rich caudate nucleus influences Huntington’s disease motor phenotype. Brain 2023; 146: 3319–3330. DOI: 10.1093/brain/awad043. [doi]
64. Grahn JA, Parkinson JA and Owen AM. The cognitive functions of the caudate nucleus. Progress in Neurobiology 2008; 86: 141–155. DOI: https://doi.org/10.1016/j.pneurobio.2008.09.004. [doi]
65. Choi Y, Shin EY and Kim S. Spatiotemporal dissociation of fMRI activity in the caudate nucleus underlies human de novo motor skill learning. Proceedings of the National Academy of Sciences 2020; 117: 23886–23897. DOI: doi:10.1073/pnas.2003963117. [doi]
66. Mason SL, Zhang J, Begeti F, et al. The role of the amygdala during emotional processing in Huntington's disease: from pre-manifest to late stage disease. Neuropsychologia 2015; 70: 80–89. 20150217. DOI: 10.1016/j.neuropsychologia.2015.02.017. [doi]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/669-02-004